메뉴 건너뛰기




Volumn 25, Issue 1, 2009, Pages 39-45

Management of Chinese patients with type 2 diabetes, 1998-2006: The Diabcare-China surveys

Author keywords

China; Diabetes care; Glycaemic control; Type 2 Diabetes

Indexed keywords

ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; CREATININE; GLITAZONE DERIVATIVE; GLUCOSE; GLYCOSIDASE INHIBITOR; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN DERIVATIVE; MEGLITINIDE; SULFONYLUREA; GLYCOSYLATED HEMOGLOBIN; INSULIN;

EID: 64249171985     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990802586079     Document Type: Article
Times cited : (75)

References (26)
  • 1
  • 2
    • 0031752685 scopus 로고    scopus 로고
    • Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
    • King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-1431
    • (1998) Diabetes Care , vol.21 , pp. 1414-1431
    • King, H.1    Aubert, R.E.2    Herman, W.H.3
  • 3
    • 0034678764 scopus 로고    scopus 로고
    • A symposium: Combining sulfonylureas and other oral agents
    • Riddle M. A symposium: combining sulfonylureas and other oral agents. Am J Med 2000;108(6A):15-22S
    • (2000) Am J Med , vol.108 , Issue.6 A
    • Riddle, M.1
  • 4
    • 67649342715 scopus 로고    scopus 로고
    • Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects
    • World Medical Association. Last amended with Note of Clarification on Paragraph 29 by the WMA General Assembly, Washington
    • World Medical Association. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. 52nd WMA General Assembly, Edinburgh, Scotland, October 2000. Last amended with Note of Clarification on Paragraph 29 by the WMA General Assembly, Washington 2002
    • (2002) 52nd WMA General Assembly, Edinburgh, Scotland, October 2000
  • 5
    • 0031851293 scopus 로고    scopus 로고
    • Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
    • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553
    • (1998) Diabet Med , vol.15 , pp. 539-553
    • Alberti, K.G.1    Zimmet, P.Z.2
  • 6
    • 0030781339 scopus 로고    scopus 로고
    • Prevalence of diabetes and its risk factors in China, 1994
    • National Diabetes Prevention and Control Cooperative Group
    • Pan XR, Yang WY, Li GW, et al. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 1997;20:1664-1669
    • (1997) Diabetes Care , vol.20 , pp. 1664-1669
    • Pan, X.R.1    Yang, W.Y.2    Li, G.W.3
  • 7
    • 67649386275 scopus 로고    scopus 로고
    • DeFronzo RA, Ferrannini E, Keen H, et al., eds. Chicester, UK: John Wiley, Chapter 70
    • DeFronzo RA, Ferrannini E, Keen H, et al., eds. International Textbook of Diabetes Mellitus, 2nd edn, Chicester, UK: John Wiley, 2004:Chapter 70
    • (2004) International Textbook of Diabetes Mellitus, 2nd Edn
  • 8
    • 0035374580 scopus 로고    scopus 로고
    • The prevalence of comorbid depression in adults with diabetes: A meta-analysis
    • Anderson Rj, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-1078 (Pubitemid 33716379)
    • (2001) Diabetes Care , vol.24 , Issue.6 , pp. 1069-1078
    • Anderson, R.J.1    Freedland, K.E.2    Clouse, R.E.3    Lustman, P.J.4
  • 9
    • 0038701750 scopus 로고    scopus 로고
    • The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy- naïve type 2 diabetes: A placebo-controlled, multicentre study
    • DOI 10.1023/A:1023495106160
    • Bech P, Moses R, Gomis R. The effect of prandial glucose regulation with repaglinide on treatment satisfaction, well-being and health status in patients with pharmacology-naïve type 2 diabetes: a placebo-controlled, multicentre study. Qual Life Res 2003;12:413-425 (Pubitemid 36609886)
    • (2003) Quality of Life Research , vol.12 , Issue.4 , pp. 413-425
    • Bech, P.1    Moses, R.2    Gomis, R.3
  • 10
    • 33847373590 scopus 로고    scopus 로고
    • Routine assessment of psychological well-being in people with diabetes - Validation of the WHO-5 Well-being Index in six countries
    • no 245
    • Shea S, Skovlund S, Bech P, et al. Routine assessment of psychological well-being in people with diabetes - validation of the WHO-5 Well-being Index in six countries. Diabetologia 2003;46(Suppl 2):A88[no 245]
    • (2003) Diabetologia , vol.46 , Issue.SUPPL. 2
    • Shea, S.1    Skovlund, S.2    Bech, P.3
  • 11
    • 33746426239 scopus 로고    scopus 로고
    • Health Care and patient-reported outcomes: Results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study
    • on behalf of the International DAWN Advisory Panel
    • Richard RR, Mark P, Linda MS; on behalf of the International DAWN Advisory Panel: Health Care and patient-reported outcomes: Results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabetes Care 2006;29:1249-1255
    • (2006) Diabetes Care , vol.29 , pp. 1249-1255
    • Richard, R.R.1    Mark, P.2    Linda, M.S.3
  • 12
    • 27944467231 scopus 로고    scopus 로고
    • The Diabetes, Attitudes, Wishes, and Needs (DAWN) Program: A new approach to improving outcomes of diabetes care
    • on behalf of the DAWN International Advisory Panel
    • Soren ES, Peyrot M; on behalf of the DAWN International Advisory Panel. The Diabetes, Attitudes, Wishes, and Needs (DAWN) Program: a new approach to improving outcomes of diabetes care. Diabetes Spectrum 2005;18:136-142
    • (2005) Diabetes Spectrum , vol.18 , pp. 136-142
    • Soren, E.S.1    Peyrot, M.2
  • 13
    • 0036059959 scopus 로고    scopus 로고
    • The DAWN (Diabetes Attitudes, Wishes and Needs) Study
    • Alberti G. The DAWN (Diabetes Attitudes, Wishes and Needs) Study. Pract Diab Int 2002;19:22-24a
    • (2002) Pract Diab Int , vol.19
    • Alberti, G.1
  • 14
    • 0036736185 scopus 로고    scopus 로고
    • When oral agents fail: Practical barriers to starting insulin
    • Korykowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes 2002;26(Suppl 3):S18-24
    • (2002) Int J Obes , vol.26 , Issue.SUPPL. 3
    • Korykowski, M.1
  • 15
    • 32144448938 scopus 로고    scopus 로고
    • Standards of medical care in diabetes - 2006
    • American Diabetes Association
    • American Diabetes Association: Standards of medical care in diabetes - 2006. Diabetes Care 2006;29:S4-42
    • (2006) Diabetes Care , vol.29
  • 16
    • 34250895451 scopus 로고    scopus 로고
    • Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus
    • DOI 10.1592/phco.27.7.948
    • Cobden D, Lee WC, Balu S, et al. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus. Pharmacotherapy 2007;27:948-962 (Pubitemid 46986681)
    • (2007) Pharmacotherapy , vol.27 , Issue.7 , pp. 948-962
    • Cobden, D.1    Lee, W.C.2    Balu, S.3    Joshi, A.V.4    Pashos, C.L.5
  • 17
    • 33751566656 scopus 로고    scopus 로고
    • Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data
    • DOI 10.1016/j.clinthera.2006.10.004, PII S014929180600244X
    • Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clinical Therapeutics 2006;28:1712-1725 (Pubitemid 44841979)
    • (2006) Clinical Therapeutics , vol.28 , Issue.10 , pp. 1712-1725
    • Lee, W.C.1    Balu, S.2    Cobden, D.3    Joshi, A.V.4    Pashos, C.L.5
  • 18
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study (UKPDS) Group
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853
    • (1998) Lancet , vol.352 , pp. 837-853
  • 19
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)UK Prospective Diabetes Study (UKPDS) Group
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854-865
    • (1998) Lancet , vol.352 , pp. 854-865
  • 20
    • 15044342214 scopus 로고    scopus 로고
    • Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus
    • DOI 10.1016/j.coph.2004.11.005, PII S1471489205000147
    • Delorme S, Chiasson JL. Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus. Curr Opin Pharmacol 2005;5:184-189 (Pubitemid 40378751)
    • (2005) Current Opinion in Pharmacology , vol.5 , Issue.2 SPEC. ISS , pp. 184-189
    • Delorme, S.1    Chiasson, J.-L.2
  • 21
    • 0036483958 scopus 로고    scopus 로고
    • Sulfonylurea Inadequacy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective diabetes Study (UKPDS 57)
    • Wright A, Burden AC, Paisey RB, et al. Sulfonylurea Inadequacy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective diabetes Study (UKPDS 57). Diabetes Care 2002;25(2):330-336
    • (2002) Diabetes Care , vol.25 , Issue.2 , pp. 330-336
    • Wright, A.1    Burden, A.C.2    Paisey, R.B.3
  • 22
    • 29944436303 scopus 로고    scopus 로고
    • IDF Clinical Guidelines Task Force. Brussels: International Diabetes Federation
    • IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. Brussels: International Diabetes Federation, 2005
    • (2005) Global Guideline for Type 2 Diabetes
  • 23
    • 0012734054 scopus 로고    scopus 로고
    • Asia-Pacific Type 2 diabetes Policy Group. Health Communications Australia Pty Limited and In Vivo Communication Pty Limited, Sydney, Australia
    • Type 2 diabetes practical targets and treatments, 3rd edn. Asia-Pacific Type 2 diabetes Policy Group. Health Communications Australia Pty Limited and In Vivo Communication Pty Limited, Sydney, Australia, 2002
    • (2002) Type 2 Diabetes Practical Targets and Treatments, 3rd Edn.
  • 24
    • 1042302783 scopus 로고    scopus 로고
    • Standards of medical care in diabetes
    • American Diabetes Association
    • American Diabetes AssociationStandards of medical care in diabetes. Diabetes Care 2004;27:S15-35
    • (2004) Diabetes Care , vol.27
  • 26
    • 0036650074 scopus 로고    scopus 로고
    • The Oxford International Diabetes Summit: Implications of the DAWN study
    • The Oxford International Diabetes Summit: Implications of the DAWN study. Pract Diab Int 2002;19:187-192
    • (2002) Pract Diab Int , vol.19 , pp. 187-192


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.